Nagehan Ersoy Tunalı

Istanbul Medeniyet University

Nagehan ERSOY TUNALI received her Ph.D., M.Sc., and B.Sc. degrees in Molecular Biology and Genetics from the Boğaziçi University, İstanbul (TR). Her Ph.D. work involved “Molecular Analysis of Polyglutamine Diseases and Investigation of the Interaction Between Huntingtin and Nuclear Receptor Corepressor”. She had the opportunity to gain experience in Huntington’s Disease (HD) research at the University of Manchester (UK), CNR-Istituto di Medicina Sperimentale e Biotecnologie (IT) and the University of Wales College of Medicine (UK). She served as the Editor-in-Chief of the Journal of Cell and Molecular Biology between 2006 and 2016. Nagehan ERSOY TUNALI is currently conducting research on genetic modifiers of HD, localization and interactions of huntingtin, molecular mechanisms of excitotoxicity in HD, diagnostic biomarker discovery in AD, and nanotechnology-based therapeutic approaches in HD and AD.

3books edited

3chapters authored

Latest work with IntechOpen by Nagehan Ersoy Tunalı

Neurodegenerative diseases represent a very large group of heterogeneous disorders affecting specific subtypes of neurons in the brain. This book contributes insight both to the awareness of the brain and its neurodegenerative states. The chapters present current knowledge regarding genetics, molecular mechanisms, and new therapeutic strategies against neurodegenerative disorders. The book is intended to serve as a source to aid clinicians and researchers in the field, and also life science readers to increase their understanding and awareness of the clinical correlations, genetic aspects, neuropathological findings, and current therapeutic interventions in neurodegenerative diseases. I believe that this book will enlighten the curiosity for neurodegeneration and also encourage researchers to work on potentially effective molecular therapies for still mysterious neurodegenerative disorders.

Go to the book